Ollila, D. W., Cirrincione, C. T., Berry, D. A., Carey, L. A., Sikov, W. M., Hudis, C. A., . . . Golshan, M. (2017). Axillary Management of Stage II/III Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-positive) and CALGB 40603 (Triple-negative). J Am Coll Surg.
Citação norma ChicagoOllila, David W., Constance T. Cirrincione, Donald A. Berry, Lisa A. Carey, William M. Sikov, Clifford A. Hudis, Eric P. Winer, and Mehra Golshan. "Axillary Management of Stage II/III Breast Cancer Patients Treated With Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-positive) and CALGB 40603 (Triple-negative)." J Am Coll Surg 2017.
MLA CitationOllila, David W., et al. "Axillary Management of Stage II/III Breast Cancer Patients Treated With Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-positive) and CALGB 40603 (Triple-negative)." J Am Coll Surg 2017.